Skip directly to content

Vaccine

A vaccine is a biological preparation used to stimulate the production of antibodies and provide immunity against one or several diseases. It is prepared from weakened or killed forms of the causative agent of a disease, its products, or a synthetic substitute, treated to act as an antigen without inducing the disease. After treatment with a vaccine, the body's immune system has learnt to recognize the agent as foreign, destroy it, and "remember" it, thus being ready to face future encounters.
Vaccines can be prophylactic (e.g. to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g. vaccines against cancer are also being investigated).
Avian flu, also known as “bird flu”, is an infection caused by avian influenza A viruses. These influenza A viruses occur naturally among birds. Wild birds worldwide get flu A infections in their intestines, but usually do not get sick from flu infections. However, avian influenza is very contagious among birds and some of these viruses can make certain domesticated bird species, including chickens, ducks, and turkeys, very sick and kill them.
Most avian influenza viruses do not cause disease in humans. However, some are zoonotic, meaning that they can infect humans and cause disease. The most well known example is the Highly Pathogenic Influenza A (H5N1) virus – also called "HPAI H5N1 virus" – currently circulating in poultry in parts of Asia and northeast Africa. It is highly contagious among birds and can be deadly to them. Infections with these viruses have occurred in humans, especially in people having direct or close contact with H5N1-infected poultry or H5N1-contaminated surfaces. HPAI H5N1 virus can infect the respiratory tract of humans causing severe respiratory illness (e.g. pneumonia and respiratory failure) and eventually leading to death. Of the few avian influenza viruses that have crossed the species barrier to infect humans, HPAI H5N1 has caused the largest number of detected cases of severe disease and death in humans. More than 600 human HPAI H5N1 cases have been reported to WHO from 15 countries in Asia, Africa, the Pacific, Europe and the Near East since November 2003. Approximately 60% of the cases have died. The majority of these cases have occurred among children and adults younger than 40 years old. Mortality has been highest in people aged 10-19 years old and young adults. Most human HPAI H5N1 cases have presented late in their illness for medical care and have been hospitalized with severe respiratory disease. However, some clinically mild HPAI H5N1 cases have been reported, especially in children.
A vaccine is a biological preparation used to stimulate the production of antibodies and provide immunity against one or several diseases. It is prepared from weakened or killed forms of the causative agent of a disease, its products, or a synthetic substitute, treated to act as an antigen without inducing the disease. After treatment with a vaccine, the body's immune system has learnt to recognize the agent as foreign, destroy it, and "remember" it, thus being ready to face future encounters.
Vaccines can be prophylactic (e.g. to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g. vaccines against cancer are also being investigated).

Swine influenza, also called pig influenza, “swine flu”, “hog flu” and “pig flu”, is an infection caused by any one of several types of swine influenza viruses, including influenza C virus and the subtypes of influenza A (H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3). Swine influenza virus is common throughout pig populations worldwide. Transmission of the virus from pigs to humans is not common and does not always lead to human flu, often resulting only in the production of antibodies in the blood. If transmission does cause human flu, it is called zoonotic swine flu. People with regular exposure to pigs are at increased risk of swine flu infection. Symptoms of zoonotic swine flu in humans are similar to those of influenza and of influenza-like illness in general, namely chills, fever, sore throat, muscle pains, severe headache, coughing, weakness and general discomfort.
In April 2009, a new strain of H1N1 virus, responsible for human influenza, was originally referred to as “swine flu” because laboratory testing showed that many of the genes in the virus were very similar to influenza viruses that normally occur in pigs in North America. However, further study has shown that the 2009 H1N1 is very different from what normally circulates in North American pigs. It has two genes from flu viruses that normally circulate in pigs in Europe and Asia and others from bird (avian) genes and human flu viruses genes. Scientists call this a "quadruple reassortant" virus.
Despite its name, the H1N1 “swine flu” virus cannot be spread by eating pork or pork products and, similar to other influenza viruses, it is typically contracted by person to person transmission through respiratory droplets. Symptoms usually last 4–6 days. Unlike most strains of influenza, H1N1 does not disproportionately infect adults older than 60 years. This virus (Probably due to previous exposure to a similar H1N1 virus) was first detected in people in the United States in April 2009 and it was as a pandemic by the World Health Organization in June 2009. It spread worldwide and, as of May 30 2010, 18138 deaths have been reported. On August 10, 2010, the World Health Organization declared the H1N1 influenza pandemic over, saying worldwide flu activity had returned to typical seasonal patterns.
An intense debate arose about the declaration of the “swine flu” as a pandemic. Critics claimed the WHO had exaggerated the danger, spreading fear and confusion rather than immediate information.
A flu follow-up study done in September 2010, found that "the risk of most serious complications was not elevated in adults or children". A 2011 study estimated that the 2009 H1N1 global infection rate was 11% to 21% lower than what was previously expected while another one, published in 2012, showed that as many as 579,000 people could have been killed by the disease, as only those fatalities confirmed by laboratory testing were included in the original number, and meant that many of those without access to health facilities went uncounted. The majority of these deaths occurred in Africa and South East Asia.

A vaccine is a biological preparation used to stimulate the production of antibodies and provide immunity against one or several diseases. It is prepared from weakened or killed forms of the causative agent of a disease, its products, or a synthetic substitute, treated to act as an antigen without inducing the disease. After treatment with a vaccine, the body's immune system has learnt to recognize the agent as foreign, destroy it, and "remember" it, thus being ready to face future encounters.
Vaccines can be prophylactic (e.g. to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g. vaccines against cancer are also being investigated).

Swine influenza, also called pig influenza, “swine flu”, “hog flu” and “pig flu”, is an infection caused by any one of several types of swine influenza viruses, including influenza C virus and the subtypes of influenza A (H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3). Swine influenza virus is common throughout pig populations worldwide. Transmission of the virus from pigs to humans is not common and does not always lead to human flu, often resulting only in the production of antibodies in the blood. If transmission does cause human flu, it is called zoonotic swine flu. People with regular exposure to pigs are at increased risk of swine flu infection. Symptoms of zoonotic swine flu in humans are similar to those of influenza and of influenza-like illness in general, namely chills, fever, sore throat, muscle pains, severe headache, coughing, weakness and general discomfort.
In April 2009, a new strain of H1N1 virus, responsible for human influenza, was originally referred to as “swine flu” because laboratory testing showed that many of the genes in the virus were very similar to influenza viruses that normally occur in pigs in North America. However, further study has shown that the 2009 H1N1 is very different from what normally circulates in North American pigs. It has two genes from flu viruses that normally circulate in pigs in Europe and Asia and others from bird (avian) genes and human flu viruses genes. Scientists call this a "quadruple reassortant" virus.
Despite its name, the H1N1 “swine flu” virus cannot be spread by eating pork or pork products and, similar to other influenza viruses, it is typically contracted by person to person transmission through respiratory droplets. Symptoms usually last 4–6 days. Unlike most strains of influenza, H1N1 does not disproportionately infect adults older than 60 years. This virus (Probably due to previous exposure to a similar H1N1 virus) was first detected in people in the United States in April 2009 and it was as a pandemic by the World Health Organization in June 2009. It spread worldwide and, as of May 30 2010, 18138 deaths have been reported. On August 10, 2010, the World Health Organization declared the H1N1 influenza pandemic over, saying worldwide flu activity had returned to typical seasonal patterns.
An intense debate arose about the declaration of the “swine flu” as a pandemic. Critics claimed the WHO had exaggerated the danger, spreading fear and confusion rather than immediate information.
A flu follow-up study done in September 2010, found that "the risk of most serious complications was not elevated in adults or children". A 2011 study estimated that the 2009 H1N1 global infection rate was 11% to 21% lower than what was previously expected while another one, published in 2012, showed that as many as 579,000 people could have been killed by the disease, as only those fatalities confirmed by laboratory testing were included in the original number, and meant that many of those without access to health facilities went uncounted. The majority of these deaths occurred in Africa and South East Asia.

Pages